203 related articles for article (PubMed ID: 22395466)
1. Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome.
Zoldoš V; Horvat T; Novokmet M; Cuenin C; Mužinić A; Pučić M; Huffman JE; Gornik O; Polašek O; Campbell H; Hayward C; Wright AF; Rudan I; Owen K; McCarthy MI; Herceg Z; Lauc G
Epigenetics; 2012 Feb; 7(2):164-72. PubMed ID: 22395466
[TBL] [Abstract][Full Text] [Related]
2. Mutations in HNF1A result in marked alterations of plasma glycan profile.
Thanabalasingham G; Huffman JE; Kattla JJ; Novokmet M; Rudan I; Gloyn AL; Hayward C; Adamczyk B; Reynolds RM; Muzinic A; Hassanali N; Pucic M; Bennett AJ; Essafi A; Polasek O; Mughal SA; Redzic I; Primorac D; Zgaga L; Kolcic I; Hansen T; Gasperikova D; Tjora E; Strachan MW; Nielsen T; Stanik J; Klimes I; Pedersen OB; Njølstad PR; Wild SH; Gyllensten U; Gornik O; Wilson JF; Hastie ND; Campbell H; McCarthy MI; Rudd PM; Owen KR; Lauc G; Wright AF
Diabetes; 2013 Apr; 62(4):1329-37. PubMed ID: 23274891
[TBL] [Abstract][Full Text] [Related]
3. Genetic and Epigenetic Association of Hepatocyte Nuclear Factor-1α with Glycosylation in Post-Traumatic Stress Disorder.
Tudor L; Konjevod M; Nedic Erjavec G; Nikolac Perkovic M; Uzun S; Kozumplik O; Zoldos V; Lauc G; Svob Strac D; Pivac N
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741825
[TBL] [Abstract][Full Text] [Related]
4. Interlaboratory evaluation of plasma N-glycan antennary fucosylation as a clinical biomarker for HNF1A-MODY using liquid chromatography methods.
Demus D; Jansen BC; Gardner RA; Urbanowicz PA; Wu H; Štambuk T; Juszczak A; Medvidović EP; Juge N; Gornik O; Owen KR; Spencer DIR
Glycoconj J; 2021 Jun; 38(3):375-386. PubMed ID: 33765222
[TBL] [Abstract][Full Text] [Related]
5. Plasma Fucosylated Glycans and C-Reactive Protein as Biomarkers of HNF1A-MODY in Young Adult-Onset Nonautoimmune Diabetes.
Juszczak A; Pavić T; Vučković F; Bennett AJ; Shah N; Pape Medvidović E; Groves CJ; Šekerija M; Chandler K; Burrows C; Rojnić Putarek N; Vučić Lovrenčić M; Ćuća Knežević J; James TJ; Gloyn AL; Lauc G; McCarthy MI; Owen KR; Gornik O
Diabetes Care; 2019 Jan; 42(1):17-26. PubMed ID: 30455330
[TBL] [Abstract][Full Text] [Related]
6. Defining the genetic control of human blood plasma N-glycome using genome-wide association study.
Sharapov SZ; Tsepilov YA; Klaric L; Mangino M; Thareja G; Shadrina AS; Simurina M; Dagostino C; Dmitrieva J; Vilaj M; Vuckovic F; Pavic T; Stambuk J; Trbojevic-Akmacic I; Kristic J; Simunovic J; Momcilovic A; Campbell H; Doherty M; Dunlop MG; Farrington SM; Pucic-Bakovic M; Gieger C; Allegri M; Louis E; Georges M; Suhre K; Spector T; Williams FMK; Lauc G; Aulchenko YS
Hum Mol Genet; 2019 Jun; 28(12):2062-2077. PubMed ID: 31163085
[TBL] [Abstract][Full Text] [Related]
7. Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approach.
P S; D TK; C GPD; R S; Zayed H
PLoS One; 2017; 12(4):e0174953. PubMed ID: 28410371
[TBL] [Abstract][Full Text] [Related]
8. Fucosylated AGP glycopeptides as biomarkers of HNF1A-Maturity onset diabetes of the young.
Tijardović M; Štambuk T; Juszczak A; Keser T; Gasperikova D; Novokmet M; Tjora E; Pape Medvidović E; Stanik J; Rasmus Njølstad P; Lauc G; Owen KR; Gornik O
Diabetes Res Clin Pract; 2022 Mar; 185():109226. PubMed ID: 35122907
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults.
Huffman JE; Knezevic A; Vitart V; Kattla J; Adamczyk B; Novokmet M; Igl W; Pucic M; Zgaga L; Johannson Å; Redzic I; Gornik O; Zemunik T; Polasek O; Kolcic I; Pehlic M; Koeleman CA; Campbell S; Wild SH; Hastie ND; Campbell H; Gyllensten U; Wuhrer M; Wilson JF; Hayward C; Rudan I; Rudd PM; Wright AF; Lauc G
Hum Mol Genet; 2011 Dec; 20(24):5000-11. PubMed ID: 21908519
[TBL] [Abstract][Full Text] [Related]
10. Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation.
Lauc G; Essafi A; Huffman JE; Hayward C; Knežević A; Kattla JJ; Polašek O; Gornik O; Vitart V; Abrahams JL; Pučić M; Novokmet M; Redžić I; Campbell S; Wild SH; Borovečki F; Wang W; Kolčić I; Zgaga L; Gyllensten U; Wilson JF; Wright AF; Hastie ND; Campbell H; Rudd PM; Rudan I
PLoS Genet; 2010 Dec; 6(12):e1001256. PubMed ID: 21203500
[TBL] [Abstract][Full Text] [Related]
11. Changes in IgG and total plasma protein glycomes in acute systemic inflammation.
Novokmet M; Lukić E; Vučković F; Ðurić Ž; Keser T; Rajšl K; Remondini D; Castellani G; Gašparović H; Gornik O; Lauc G
Sci Rep; 2014 Mar; 4():4347. PubMed ID: 24614541
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic modulation of the HeLa cell membrane N-glycome.
Horvat T; Mužinić A; Barišić D; Bosnar MH; Zoldoš V
Biochim Biophys Acta; 2012 Sep; 1820(9):1412-9. PubMed ID: 22192783
[TBL] [Abstract][Full Text] [Related]
13. Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes.
Rudman N; Kaur S; Simunović V; Kifer D; Šoić D; Keser T; Štambuk T; Klarić L; Pociot F; Morahan G; Gornik O
Diabetologia; 2023 Jun; 66(6):1071-1083. PubMed ID: 36907892
[TBL] [Abstract][Full Text] [Related]
14. Plasma N-glycome composition associates with chronic low back pain.
Trbojević-Akmačić I; Vučković F; Vilaj M; Skelin A; Karssen LC; Krištić J; Jurić J; Momčilović A; Šimunović J; Mangino M; De Gregori M; Marchesini M; Dagostino C; Štambuk J; Novokmet M; Rauck R; Aulchenko YS; Primorac D; Kapural L; Buyse K; Mesotten D; Williams FMK; van Zundert J; Allegri M; Lauc G
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2124-2133. PubMed ID: 29981899
[TBL] [Abstract][Full Text] [Related]
15. Changes in total plasma and serum N-glycome composition and patient-controlled analgesia after major abdominal surgery.
Gudelj I; Baciarello M; Ugrina I; De Gregori M; Napolioni V; Ingelmo PM; Bugada D; De Gregori S; Đerek L; Pučić-Baković M; Novokmet M; Gornik O; Saccani Jotti G; Meschi T; Lauc G; Allegri M
Sci Rep; 2016 Aug; 6():31234. PubMed ID: 27501865
[TBL] [Abstract][Full Text] [Related]
16. High-throughput glycomics: optimization of sample preparation.
Akmačić IT; Ugrina I; Štambuk J; Gudelj I; Vučković F; Lauc G; Pučić-Baković M
Biochemistry (Mosc); 2015 Jul; 80(7):934-42. PubMed ID: 26542006
[TBL] [Abstract][Full Text] [Related]
17. Plasma protein N-glycome composition associates with postprandial lipaemic response.
Louca P; Štambuk T; Frkatović-Hodžić A; Nogal A; Mangino M; Berry SE; Deriš H; Hadjigeorgiou G; Wolf J; Vinicki M; Franks PW; Valdes AM; Spector TD; Lauc G; Menni C
BMC Med; 2023 Jul; 21(1):231. PubMed ID: 37400796
[TBL] [Abstract][Full Text] [Related]
18. High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations.
Pucić M; Knezević A; Vidic J; Adamczyk B; Novokmet M; Polasek O; Gornik O; Supraha-Goreta S; Wormald MR; Redzić I; Campbell H; Wright A; Hastie ND; Wilson JF; Rudan I; Wuhrer M; Rudd PM; Josić D; Lauc G
Mol Cell Proteomics; 2011 Oct; 10(10):M111.010090. PubMed ID: 21653738
[TBL] [Abstract][Full Text] [Related]
19. Towards personalized diagnostics via longitudinal study of the human plasma N-glycome.
Hennig R; Cajic S; Borowiak M; Hoffmann M; Kottler R; Reichl U; Rapp E
Biochim Biophys Acta; 2016 Aug; 1860(8):1728-38. PubMed ID: 27038647
[TBL] [Abstract][Full Text] [Related]
20. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes.
Harries LW; Ellard S; Stride A; Morgan NG; Hattersley AT
Hum Mol Genet; 2006 Jul; 15(14):2216-24. PubMed ID: 16760222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
